Market Place
Sourcing Support
Abvance Gets $3.9M From Helmsley For Insulin Development
10 Sep 2024 //
GLOBENEWSWIRE
NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
29 Jul 2024 //
ACCESSWIRE
Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion
25 Apr 2023 //
REUTERS
Zucara Tx Publishes Preclinical Study Demonstrating ZT-01`s in Type 1 Diabetes
08 Feb 2022 //
PRNEWSWIRE
Sciwind Completes Enrollment in Phase 2 Trial of XW003 in Type 2 Diabetes
09 Dec 2021 //
PRNEWSWIRE
Viking to Present Preclinical Data on Novel Dual GLP-1/GIP Agonists
25 Oct 2021 //
PRNEWSWIRE
Eli Lilly ordered to pay royalties on blockbuster diabetes drugs
22 Oct 2021 //
ENDPTS
Enforcement Report - Week of October 20, 2021
20 Oct 2021 //
FDA
Eli Lilly`s recently recalled glucagon kits found at Indianapolis site — report
08 Oct 2021 //
ENDPTS
Recalled Eli Lilly Glucagon Kits Were Manufactured at Factory with Troubled Past
05 Oct 2021 //
BIOSPACE
Eli Lilly & Co. Issues Voluntary Nationwide Recall of Glucagon Emergency Kit
26 Sep 2021 //
FDA
Xeris Receives European Commission Approval of Ogluo™ (glucagon)
11 Feb 2021 //
BUSINESSWIRE
U.S. FDA grants orphan drug designation to AmideBio`s glucagon analog
24 Apr 2020 //
PR NEWSWIR
Xeris Pharma`s Glucagon Receives Approval in US
11 Sep 2019 //
FDA
Eli Lilly`s hypoglycemia treatment wins FDA approval
26 Jul 2019 //
REUTERS
Startup Neuraly Launches with $36 Million: Targets Neurodegenerative Diseases
19 Jul 2018 //
BIOSPACE
Startup Neuraly Raises $36M
18 Jul 2018 //
BUSINESSWIRE
EU green light for Cimzia to treat psoriasis
03 Jul 2018 //
PHARMA TIMES
Xeris hauls $55M in new funding to bring glucagon pen to market
09 Mar 2018 //
ENDPTS
Xeris Pharmaceuticals Scores $41 Million Series C Financing
07 Jan 2016 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.